Mumps virus reinfection is not a rare event confirmed by reverse transcription loop-mediated isothermal amplification

Journal of Medical Virology

Volumn 80, Issue 3, 2008, Pages 517-523

  Yoshida, Naoko ^a   Fujino, Motoko ^a   Miyata, Akiko ^b   Nagai, Takao ^c   Kamada, Makoto ^d   Sakiyama, Hiroshi ^e   Ihara, Toshiaki ^f   Kumagai, Takuji ^g   Okafuji, Teruo ^h   Okafuji, Takao ^h   Nakayama, Tetsuo ^a  

^a KITASATO UNIVERSITY   (Japan)

^b Miyata Pediatric Clinic   (Japan)

^c Nagai Pediatric Clinic   (Japan)

^d West Sapporo Pediatrics Clinic   (Japan)

^e Sakiyama Pediatric Clinic   (Japan)

^f MIE NATIONAL HOSPITAL   (Japan)

^g Kumagai Pediatric Clinic   (Japan)

^h Okafuji Pediatric Clinic   (Japan)

Author keywords

Avidity tests; IgG EIA; IgM EIA; Reinfection; Vaccine failure

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; GENE AMPLIFICATION; HUMAN; MAJOR CLINICAL STUDY; MUMPS; MUMPS VIRUS; NONHUMAN; OUTPATIENT DEPARTMENT; REINFECTION; REVERSE TRANSCRIPTION; REVERSE TRANSCRIPTION LOOP MEDIATED ISOTHERMAL AMPLIFICATION; SEROLOGY; VIRUS DETECTION; VIRUS GENOME; VIRUS ISOLATION; VIRUS LOAD;

ANTIBODIES, VIRAL; GENOME, VIRAL; GENOTYPE; HUMANS; MUMPS; MUMPS VACCINE; MUMPS VIRUS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; RECURRENCE; VIRAL LOAD;

MUMPS VIRUS;

EID: 38849147769     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21106     Document Type: Article

References (34)

1. Briss PA, Fehrs LJ, Parker PA, Wright PF, Sannella EC, Hutchenson RH, Schaffner W. 1994. Sustained transmission of mumps in a highly vaccinated population: Assessment of primary vaccine failure and waning vaccine-induced immunity. J Infect Dis 169: 77-82.
2. Carbone KM, Wolinsky JS. 2001. Mumps virus. In: Fields Virology. 4th edition. Philadelphia, PA: Williams & Wilkins. pp 1381-1400.
3. CDC. 1998. Measles, mumps, rubella - vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 47:1-60.
4. CDC. 2006a. Mumps epidemic - United Kingdom, 2004-2005. MMWR 55:173-175.
5. CDC. 2006b. Mumps outbreak at a summer camp - New York, 2005. MMWR 55:175-177.
6. CDC. 2006c. Update: Multistate outbreak of mumps - United States, January 1-May 2, 2006. MMWR 55:559-563.
7. Crowley B, Afzal MA. 2002. Mumps virus reinfection - clinical findings and serological vagaries. Commun Dis Public Health 5:311-313.
8. Davidkin I, Jokinen S, Paananen A, Leinikki P, Peltola H. 2005. Etiology of mumps-like illness in children and adolescents vaccinated for measles, mumps, and rubella. J Infect Dis 191:719-723.
9. Donaghy M, Cameron JC, Friederichs V. 2005. Increasing incidence of mumps in Scotland: Options for reducing transmission. J Clin Virol 35:121-129.
10. Gut JP, Lablache C, Behr S, Kirn A. 1995. Symptomatic mumps virus reinfections. J Med Virol 45:17-23.
11. Harling R, White JM, Ramsay ME, Macsween KF, van den Bosch C. 2005. The effectiveness of the mumps component of the MMR vaccine: A case control study. Vaccine 23:4070-4074.
12. Inou Y, Nakayama T, Yoshida N, Uejima H, Yuri K, Kamada M, Kumagai T, Sakiyama H, Miyata A, Ochiai H, Ihara T, Okafuji T, Okafuji T, Nagai T, Suzuki E, Shimomura K, Ito Y, Miyazaki C. 2004. Molecular epidemiology of mumps virus in Japan and proposal of two new genotypes. J Med Virol 73:97-104.
13. Jin L, Rima B, Brown D, Örvell C, Tecle T, Afzal M, Uchida K, Nakayama T, Song JW, Kang C, Rota PA, Xu W, Featherstone D. 2005. Proposal for genetic characterisation of wild-type mumps strains: Preliminary standardisation of the nomenclature. Arch Virol 150:1903-1909.
14. Kashiwagi Y, Kawashima H, Takekuma K, Hoshika A, Mori T, Nakayama T. 1997. Detection of mumps virus genome directly from clinical samples and a simple method for genetic differentiation of the Hoshino vaccine strain from wild strains of mumps virus. J Med Virol 52:195-199.
15. Kimura M, Kuno-Sakai H, Yamazaki S, Yamada A, Hishiyama M, Kamiya H, Ueda K, Murase T, Hirayama M, Oya A, Nozaki S, Murata R. 1996. Adverse events associated with MMR vaccines in Japan. Acta Paediatr Jpn 38:205-211.
16. McQuone SJ. 1992. Acute viral and bacterial infections of the salivary glands. Otollaryngol Clin North Am 118:469-471.
17. Mori Y, Kitao M, Tomita N, Notomi T. 2004. Real-time turbidimetry of LAMP reaction for quantifying template DNA. J Biochem Biophys Methods 59:145-157.
18. Nagai T, Okafuji T, Miyazaki C, Ito Y, Kamada M, Kumagai T, Yuri K, Sakiyama H, Miyata A, Ihara T, Ochiai H, Shimomura K, Suzuki E, Torigoe S, Igarashi M, Kase T, Okuno Y, Nakayama T. 2007. A comparative study of the incidence of aseptic meningitis in symptomatic natural mumps patients and monovalent mumps vaccine recipients in Japan. Vaccine 25:2742-2747.
19. Narita M, Matsuzono Y, Takekoshi Y, Yamada S, Itakura O, Kubota M, Kikuta H, Togashi T. 1998. Analysis of mumps vaccine failure by means of avidity testing for mumps virus-specific immunoglobulin G. Clin Diagn Lab Immunol 5:799-803.
20. Nöjd J, Tecle T, Samuelsson A, Örvell C. 2001. Mumps virus neutralizing antibodies do not protect against reinfection with a heterologous mumps genotype. Vaccine 19:1727-1731.
21. Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, Hase T. 2000. Loop-mediated isothermal amplification of DNA Nucleic Acids Res 28:e63.
22. Okafuji T, Yoshida N, Fujino M, Motegi Y, Ihara T, Ota Y, Notomi T, Nakayama T. 2005. Rapid diagnostic method for the detection of mumps virus genome by loop-mediated isothermal amplification. J Clin Microbiol 43:1625-1631.
23. Peltola H, Heinonen OP, Valle M, Paunio M, Virtanen M, Karanko V, Cantell K. 1994. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. N Engl J Med 331:1397-1402.
24. Plotkin S. 2004. Mumps vaccine. In: Plotkin S, Orenstein WA, editors. Vaccines 4th edition. Philadelphia: Saunders. pp 441-469.
25. Rubin S, Mauldin J, Chumakov K, Vanderzanden J, Iskow R, Carbone K. 2006. Serological and phylogenetic evidence of monotypic immune responses to different mumps virus strains. Vaccine 24: 2662-2668.
26. Šantak M, Košutić-Gulija T, Tešović G, Ljubin-Sternak S, Gjenero-Margan I, Betica-Radić L, Forčić D. 2006. Mumps virus strains isolated in Croatia in 1998 and 2005: Genotyping and putative antigenic relatedness to vaccine strains. J Med Virol 78:638-643.
27. Schlegel M, Osterwalder JJ, Galeazzi RL, Vernazza PL. 1999. Comparative efficacy of three mumps vaccines during disease outbreak in eastern Switzerland: Cohort study. BMJ 319:352-353.
28. Takahashi M, Nakayama T, Kashiwagi Y, Takami T, Sonoda S, Yamanaka T, Ochiai H, Ihara T, Tajima T. 2000. Single genotype of measles virus is dominant whereas several genotypes of mumps virus are co-circulating. J Med Virol 62:278-285.
29. Takeuchi K, Tanabayashi K, Hishiyama M, Yamada A. 1996. The mumps virus SH protein is a membrane protein and not essential for virus growth. Virology 225:156-162.
30. Ueda K, Miyazaki C, Hidaka Y, Okada K, Kusuhara K, Kadoya R. 1995. Aseptic meningitis caused by measles-mumps-rubella vaccine in Japan. Lancet 346:701-702.
31. Utz S, Richard JL, Capaul S, Matter HC, Hrisoho MG, Mühlemann K. 2004. Phylogenetic analysis of clinical mumps virus isolates from vaccinated and non-vaccinated patients with mumps during an outbreak, Switzerland 1998-2000. J Med Virol 73:91-96.
32. Vandermeulen C, Roelants M, Vermoere M, Roseeuw K, Goubau P, Hoppenbrouwers K. 2004. Outbreak of mumps in a vaccinated child population: A question of vaccine failure? Vaccine 22:2713-2716.
33. Vinagre C, Martinez MJ, Avendano LF, Landaeta M, Pinto ME. 2003. Virology of infantile chronic recurrent parotitis in Santiago de Chile. J Med Virol 70:459-462.
34. Watson-Creed G, Saunders A, Scott J, Lowe L, Pettipas J, Hatchette TF. 2006. Two successive outbreaks of mumps in Nova Scotia among vaccinated adolescents and young adults. CMAJ 175:483-488.